Status:
COMPLETED
Study of ORL-1B in Patients With Biotinidase Deficiency
Lead Sponsor:
Orpha Labs
Conditions:
Biotinidase Deficiency
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE1
PHASE2
Brief Summary
An Open-label, Single-arm, Phase 2 Study of Biotin in Patients With Biotinidase Deficiency.
Eligibility Criteria
Inclusion
- Diagnosis of biotinidase deficiency.
- Less than 18 years old.
Exclusion
- Diagnosis of any other disease that is not a manifestation of biotinidase deficiency.
Key Trial Info
Start Date :
August 31 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03269045
Start Date
August 31 2013
End Date
January 1 2018
Last Update
January 17 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.